Yohei worked at the Industrial Bank of Japan, Limited (now Mizuho Bank), where he engaged in corporate finance (both debt finance and equity finance). In 2006, Yohei joined ARKRAY, Inc.'s Corporate Strategy Division, where he was responsible for leading numerous projects with domestic and overseas companies, including business alliances, joint ventures, acquisitions, and the establishment of new subsidiaries. He was then placed in charge of managing ARKRAY's China subsidiary, and in 2021, he established and took charge of the CVC Department, which he currently oversees.

Wei Cong graduated from the National University of Singapore's Faculty of Law with an LLB Second Class Honors Upper degree, and practiced as a qualified corporate lawyer in Singapore before moving into venture capital in 2015. He has since handled numerous early-stage and growth-stage investments as an Investment Manager at SPH Ventures and NUS Enterprise, respectively. In January 2022, Wei Cong joined the CVC Department at ARKRAY&PARTNERS PTE. LTD. in Singapore.

At ARKRAY CVC, Wei Cong is mainly in charge of sourcing, researching and analyzing potential investments, bringing investments through the entire deal process, and managing portfolio companies. In addition, Wei Cong also handles outreach with ecosystem partners in regions like Southeast Asia, East Asia, India and Israel.

Graduated from Indian Institute of Technology – Madras with Bachelors and Masters in Mechanical Engineering, Ganesh has an experience in working with deeptech ventures in VC firms like Social Alpha and Factor[e] Ventures, evaluating external innovations in Shell, and managing organic and inorganic growth strategies at Pluss Advanced Technologies. With a career at the confluence of innovation, technology and venture capital, Ganesh has performed techno-commercial evaluations, concluded due-diligence, led several deals, and managed investments in deeptech start-ups.Ganesh joined the Corporate Venture Capital Team of ARKRAY in May 2023.
At ARKRAY, Ganesh scouts for innovative ventures in the Healthcare and Lifesciences sector, evaluates investment opportunities, and supports portfolio companies.

Fiona joined ARKRAY after earning a Master of Engineering in biotechnology (majoring in molecular biology) from a university in Japan. In the Product Development Department of ARKRAY, she has been involved in the development of in-vitro diagnostic products from the early stage of development through to manufacturing transfer. In 2019, Fiona joined the Market Research team, where she worked on domestic and international market research and customer analysis. In March 2022, she joined the CVC Department. At ARKRAY CVC, Fiona is responsible for sourcing, researching the technologies and markets of potential investment targets, analyzing potential investment targets, and supporting portfolio companies through ARKRAY 4U, a proprietary startup support program.